Eli Lilly Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly

LLY 1,075

+0.4%

3:43 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: James Baker who wrote (286)	8/7/1998 8:00:00 AM
From: peter chin	of 642

approval doesnt necessarily mean sales. while europe will be an important market in the future, it accounts for little of lilly's sales at this point with any product they have. in addition, the biggest issue for evista, once approved, is selling preventive medicine. patients and doctors are loathe to treat something that is not present yet. this is one of the biggest issues for lilly with evista. i do agree that when data like the osteop. data comes in, this can't help but improve sales. p chin

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next